SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-000329
Filing Date
2024-01-02
Accepted
2024-01-02 16:09:27
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2332968d2_s1a.htm 424B3 174911
2 GRAPHIC tm2332968d2_s1aimg001.jpg GRAPHIC 20872
3 GRAPHIC tm2332968d2_s1aimg002.jpg GRAPHIC 81554
4 GRAPHIC tm2332968d2_s1aimg003.jpg GRAPHIC 21193
  Complete submission text file 0001104659-24-000329.txt   346668
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276145 | Film No.: 24502465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)